000728 国元证券
已收盘 04-30 15:00:00
资讯
新帖
简况
国元证券:给予长盛轴承增持评级
证券之星 · 05-03 07:50
国元证券:给予长盛轴承增持评级
国元证券:给予丸美生物买入评级
证券之星 · 05-01
国元证券:给予丸美生物买入评级
国元证券:给予江苏神通买入评级
证券之星 · 05-01
国元证券:给予江苏神通买入评级
国元证券:给予运机集团买入评级
证券之星 · 04-30
国元证券:给予运机集团买入评级
国元证券:给予东华测试增持评级
证券之星 · 04-30
国元证券:给予东华测试增持评级
国元证券:给予恒帅股份增持评级
证券之星 · 04-30
国元证券:给予恒帅股份增持评级
国元证券:给予上海家化买入评级
证券之星 · 04-30
国元证券:给予上海家化买入评级
国元证券:给予神州泰岳买入评级
证券之星 · 04-30
国元证券:给予神州泰岳买入评级
国元证券(000728)4月18日股东户数9.91万户,较上期减少0.12%
证券之星 · 04-29
国元证券(000728)4月18日股东户数9.91万户,较上期减少0.12%
国元证券:一季度归母净利润6.41亿元 同比增长38.4%
中国 · 04-29
国元证券:一季度归母净利润6.41亿元 同比增长38.4%
国元证券一季度营收15.19亿元 净利润同比增38.40%
东方财富 · 04-29
国元证券一季度营收15.19亿元 净利润同比增38.40%
图解国元证券一季报:第一季度单季净利润同比增38.40%
证券之星 · 04-28
图解国元证券一季报:第一季度单季净利润同比增38.40%
国元证券:给予珀莱雅买入评级
证券之星 · 04-27
国元证券:给予珀莱雅买入评级
国元证券:给予润本股份增持评级
证券之星 · 04-27
国元证券:给予润本股份增持评级
国元证券:给予会通股份买入评级
证券之星 · 04-27
国元证券:给予会通股份买入评级
迈普医学:4月25日接受机构调研,华创证券、国元证券等多家机构参与
证券之星 · 04-26
迈普医学:4月25日接受机构调研,华创证券、国元证券等多家机构参与
国元证券:首次覆盖太龙药业给予买入评级
证券之星 · 04-25
国元证券:首次覆盖太龙药业给予买入评级
国元证券给予上海电影买入评级,2024年年报及2025年一季报点评:2025Q1业绩高增,以IP带动新业务成长
每日经济新闻 · 04-25
国元证券给予上海电影买入评级,2024年年报及2025年一季报点评:2025Q1业绩高增,以IP带动新业务成长
国元证券:公司高度重视市值管理工作,同时会按照既定的战略,努力做好经营管理
证券之星 · 04-24
国元证券:公司高度重视市值管理工作,同时会按照既定的战略,努力做好经营管理
国元证券:给予锦波生物买入评级
证券之星 · 04-24
国元证券:给予锦波生物买入评级
加载更多
公司概况
公司名称:
国元证券股份有限公司
所属行业:
资本市场服务
上市日期:
1997-06-16
主营业务:
国元证券股份有限公司的主营业务是综合金融服务的提供、研发和销售。公司的主要产品是财富信用业务、自营业务、投资银行业务、资产管理业务、机构业务、国际业务。公司荣获安徽省政府“服务地方实体经济发展评价优秀”、中国人民银行与中国证监会“金融科技发展奖”、中国证券业协会。
发行价格:
7.20
{"stockData":{"symbol":"000728","market":"SZ","secType":"STK","nameCN":"国元证券","latestPrice":7.46,"timestamp":1745996637000,"preClose":7.48,"halted":0,"volume":26377344,"delay":0,"changeRate":-0.0027,"floatShares":4364000000,"shares":4364000000,"eps":0.5551,"marketStatus":"已收盘","change":-0.02,"latestTime":"04-30 15:00:00","open":7.51,"high":7.53,"low":7.45,"amount":198000000,"amplitude":0.0107,"askPrice":7.47,"askSize":12035,"bidPrice":7.46,"bidSize":2982,"shortable":0,"etf":0,"ttmEps":0.5551,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1746495000000},"marketStatusCode":5,"adr":0,"adjPreClose":7.48,"symbolType":"stock","openAndCloseTimeList":[[1745976600000,1745983800000],[1745989200000,1745996400000]],"highLimit":8.23,"lowLimit":6.73,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":4363777891,"isCdr":false,"pbRate":0.88,"roa":"--","peRate":13.43902,"roe":"1.73%","epsLYR":0.51,"committee":-0.381561,"marketValue":32554000000,"turnoverRate":0.006,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2025-05-06。","floatMarketCap":32554000000},"requestUrl":"/m/hq/s/000728","defaultTab":"news","newsList":[{"id":"2532840903","title":"国元证券:给予长盛轴承增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2532840903","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532840903?lang=zh_cn&edition=full","pubTime":"2025-05-03 15:50","pubTimestamp":1746258624,"startTime":"0","endTime":"0","summary":"国元证券股份有限公司龚斯闻,冯健然近期对长盛轴承进行研究并发布了研究报告《2024年年度报告及2025年一季报点评:Q1稳健增长,关注机器人轴承及丝杠产品》,给予长盛轴承增持评级。 盈利能力保持稳定,费用控制良好 长盛轴承通过优化生产工艺与降本增效保持了稳健盈利能力。最新盈利预测明细如下:该股最近90天内共有3家机构给出评级,买入评级1家,增持评级2家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050300003609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000728","300718"],"gpt_icon":0},{"id":"2532501105","title":"国元证券:给予丸美生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2532501105","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532501105?lang=zh_cn&edition=full","pubTime":"2025-05-01 08:46","pubTimestamp":1746060386,"startTime":"0","endTime":"0","summary":"国元证券股份有限公司李典近期对丸美生物进行研究并发布了研究报告《2024年年报及2025年一季报点评:24年营收利润高增,大单品表现亮眼》,给予丸美生物买入评级。分品牌来看,主品牌丸美24年营收20.55亿元,同比+31.69%。我们预计2025-2027年公司EPS分别为1.14/1.46/1.79元,对应PE41/32/27倍,维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有21家机构给出评级,买入评级16家,增持评级5家;过去90天内机构目标均价为47.04。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050100006793.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603983","000728"],"gpt_icon":0},{"id":"2532011021","title":"国元证券:给予江苏神通买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2532011021","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532011021?lang=zh_cn&edition=full","pubTime":"2025-05-01 08:46","pubTimestamp":1746060385,"startTime":"0","endTime":"0","summary":"国元证券股份有限公司龚斯闻,许元琨,冯健然近期对江苏神通进行研究并发布了研究报告《2024年年度报告点评:核电订单高增,核电机组批复高景气》,给予江苏神通买入评级。预计公司2025-2027年分别实现营收24.17/26.77/29.80亿元,归母净利润为3.47/4.08/4.69亿元,EPS为0.68/0.80/0.92元/股,对应PE为15.97/13.58/11.81倍,维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有7家机构给出评级,买入评级6家,增持评级1家;过去90天内机构目标均价为15.75。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050100006791.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000728","002438"],"gpt_icon":0},{"id":"2531023039","title":"国元证券:给予运机集团买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2531023039","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531023039?lang=zh_cn&edition=full","pubTime":"2025-04-30 20:06","pubTimestamp":1746014799,"startTime":"0","endTime":"0","summary":"国元证券股份有限公司龚斯闻,冯健然近期对运机集团进行研究并发布了研究报告《运机集团2024年度及2025年一季度报告点评:订单结构优化,长期盈利向上》,给予运机集团买入评级。 风险提示 全球宏观经济波动风险;下游需求不及预期风险;账款回收不及预期风险最新盈利预测明细如下:该股最近90天内共有3家机构给出评级,买入评级3家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000043441.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000728","001288"],"gpt_icon":0},{"id":"2531038196","title":"国元证券:给予东华测试增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2531038196","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531038196?lang=zh_cn&edition=full","pubTime":"2025-04-30 19:03","pubTimestamp":1746010997,"startTime":"0","endTime":"0","summary":"国元证券股份有限公司龚斯闻,许元琨,冯健然近期对东华测试进行研究并发布了研究报告《2024年年度报告点评及2025年一季报点评:营收稳步增长,Q1表现亮眼》,给予东华测试增持评级。其中第四季度公司实现收入1.48亿元,同比增长104.03%,实现归母净利润0.23亿元,同比增长321.57%。最新盈利预测明细如下:该股最近90天内共有9家机构给出评级,买入评级7家,增持评级2家;过去90天内机构目标均价为50.04。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000040676.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300354","000728"],"gpt_icon":0},{"id":"2531774439","title":"国元证券:给予恒帅股份增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2531774439","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531774439?lang=zh_cn&edition=full","pubTime":"2025-04-30 14:25","pubTimestamp":1745994358,"startTime":"0","endTime":"0","summary":"国元证券股份有限公司刘乐,陈烨尧近期对恒帅股份进行研究并发布了研究报告《公司点评:业绩符合预期,主动感知清洗进入兑现期》,给予恒帅股份增持评级。 公司2024年及2025年初增速放缓主要原因系流体业务产品营收受到合资收缩影响 公司流体业务产品主要客户涵盖国内外知名的新能源及燃油车整车厂,随着汽车行业的成本竞争加剧,公司该业务的传统板块存在一定的增长压力。维持“增持”评级。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000025383.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300969","000728"],"gpt_icon":0},{"id":"2531474557","title":"国元证券:给予上海家化买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2531474557","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531474557?lang=zh_cn&edition=full","pubTime":"2025-04-30 08:37","pubTimestamp":1745973427,"startTime":"0","endTime":"0","summary":"国元证券股份有限公司李典近期对上海家化进行研究并发布了研究报告《2024年报及2025年一季报点评:25Q1净利环比扭亏为盈,静待调整显效》,给予上海家化买入评级。 投资建议与盈利预测 上海家化为国内老牌日化企业,品牌、产品、渠道及组织持续调整升级。最新盈利预测明细如下:该股最近90天内共有13家机构给出评级,买入评级9家,增持评级4家;过去90天内机构目标均价为27.13。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000011887.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600315","000728"],"gpt_icon":0},{"id":"2531745506","title":"国元证券:给予神州泰岳买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2531745506","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531745506?lang=zh_cn&edition=full","pubTime":"2025-04-30 08:37","pubTimestamp":1745973420,"startTime":"0","endTime":"0","summary":"国元证券股份有限公司李典近期对神州泰岳进行研究并发布了研究报告《2024年年报及2025年一季报点评:核心产品稳健增长,关注新品上线表现》,给予神州泰岳买入评级。2024年,公司海外及中国港澳台地区实现营收49.06亿元,同比+12.84%。我们预计2025-2027年EPS为0.67/0.75/0.81元,对应PE16/15/14倍,维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有10家机构给出评级,买入评级9家,增持评级1家;过去90天内机构目标均价为14.95。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000011882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300002","000728"],"gpt_icon":0},{"id":"2531209561","title":"国元证券(000728)4月18日股东户数9.91万户,较上期减少0.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531209561","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531209561?lang=zh_cn&edition=full","pubTime":"2025-04-29 17:39","pubTimestamp":1745919545,"startTime":"0","endTime":"0","summary":"证券之星消息,近日国元证券披露,截至2025年4月18日公司股东户数为9.91万户,较4月10日减少122.0户,减幅为0.12%。在证券行业个股中,国元证券股东户数低于行业平均水平,截至4月18日,证券行业平均股东户数为17.6万户。从股价来看,2025年4月10日至2025年4月18日,国元证券区间跌幅为0.27%,在此期间股东户数减少122.0户,减幅为0.12%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042900033847.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0276","BK0012","BK0183","000728","BK0028","BK0188"],"gpt_icon":0},{"id":"2531020123","title":"国元证券:一季度归母净利润6.41亿元 同比增长38.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531020123","media":"中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531020123?lang=zh_cn&edition=full","pubTime":"2025-04-29 16:53","pubTimestamp":1745916780,"startTime":"0","endTime":"0","summary":"中证报中证网讯(记者马爽)4月28日晚间,国元证券发布的2025年一季度报告显示,报告期内,公司实现营业收入15.19亿元,同比增长38.37%;归属于母公司所有者的净利润6.41亿元,同比增长38.4%;基本每股收益0.15元,同比增长36.36%。国元证券表示,公司本期营业收入和净利润等指标增长的主要原因是财富信用、证券投资交易和投资银行业务实现业绩同比增幅较大所致。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-04-29/doc-ineuvnxu1003223.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000728"],"gpt_icon":0},{"id":"2531524219","title":"国元证券一季度营收15.19亿元 净利润同比增38.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531524219","media":"东方财富","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531524219?lang=zh_cn&edition=full","pubTime":"2025-04-29 09:27","pubTimestamp":1745890020,"startTime":"0","endTime":"0","summary":"上证报中国证券网讯 4月28日晚间,国元证券发布2025年一季报。报告期内,公司实现营业总收入15.19亿元,同比增长38.37%;净利润6.41亿元,同比增长38.40%;扣非净利润6.34亿元,同比增长38.00%。其中,投资收益同比大增93.55%至9.48亿元;手续费及佣金净收入增长57.14%至4.45亿元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-04-29/doc-ineuuwac5897386.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000728"],"gpt_icon":0},{"id":"2531250368","title":"图解国元证券一季报:第一季度单季净利润同比增38.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531250368","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531250368?lang=zh_cn&edition=full","pubTime":"2025-04-29 03:56","pubTimestamp":1745870203,"startTime":"0","endTime":"0","summary":"证券之星消息,国元证券2025年一季报显示,公司主营收入15.19亿元,同比上升38.37%;归母净利润6.41亿元,同比上升38.4%;扣非净利润6.34亿元,同比上升38.0%;负债率78.3%,投资收益9.48亿元。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042900001989.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000728"],"gpt_icon":0},{"id":"2530485075","title":"国元证券:给予珀莱雅买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2530485075","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530485075?lang=zh_cn&edition=full","pubTime":"2025-04-27 14:15","pubTimestamp":1745734530,"startTime":"0","endTime":"0","summary":"国元证券股份有限公司李典近期对珀莱雅进行研究并发布了研究报告《2024年报及2025年一季报点评:24年净利润+30%,产品矩阵稳步拓展》,给予珀莱雅买入评级。主品牌珀莱雅24年实现收入85.81亿元,同比+19.55%。预计2025-2027年EPS分别为4.59/5.32/6.06元/股,对应PE为17/14/13x,维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有11家机构给出评级,买入评级9家,增持评级2家;过去90天内机构目标均价为136.7。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042700005288.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000728","603605"],"gpt_icon":0},{"id":"2530087511","title":"国元证券:给予润本股份增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2530087511","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530087511?lang=zh_cn&edition=full","pubTime":"2025-04-27 08:00","pubTimestamp":1745712058,"startTime":"0","endTime":"0","summary":"国元证券股份有限公司李典近期对润本股份进行研究并发布了研究报告《2024年年报及2025年一季报点评:25Q1增长提速,新产品新渠道贡献增量》,给予润本股份增持评级。非平台经销商实现收入3.47亿元,同比增长39.64%,毛利率同比增长1.15pct。最新盈利预测明细如下:该股最近90天内共有9家机构给出评级,买入评级8家,增持评级1家;过去90天内机构目标均价为42.0。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042700002511.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603193","000728"],"gpt_icon":0},{"id":"2530087151","title":"国元证券:给予会通股份买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2530087151","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530087151?lang=zh_cn&edition=full","pubTime":"2025-04-27 08:00","pubTimestamp":1745712056,"startTime":"0","endTime":"0","summary":"国元证券股份有限公司龚斯闻,张帅峰近期对会通股份进行研究并发布了研究报告《2024年年报&2025年一季报点评:盈利能力稳中有升,多元布局新兴领域》,给予会通股份买入评级。 会通股份 事件: 公司发布《2024年年报》和《2025年一季报》。维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有2家机构给出评级,买入评级2家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042700002507.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000728","688219"],"gpt_icon":0},{"id":"2530491731","title":"迈普医学:4月25日接受机构调研,华创证券、国元证券等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2530491731","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530491731?lang=zh_cn&edition=full","pubTime":"2025-04-26 16:01","pubTimestamp":1745654483,"startTime":"0","endTime":"0","summary":"目前,迈普医学已发展为中国领先且是国内为数不多进入全球高端市场的医疗器械公司之一,旨在成为一家为客户提供整体解决方案的平台型医疗器械企业。2024 年度,公司颅颌面修补及固定系统实现销售收入 7,989.63 万元,比上年同期增长 31.05%。该股最近90天内共有1家机构给出评级,买入评级1家;过去90天内机构目标均价为50.62。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042600010695.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","BK0276","BK0183","BK0012","BK0251","000728","161027","301033"],"gpt_icon":0},{"id":"2530902803","title":"国元证券:首次覆盖太龙药业给予买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2530902803","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530902803?lang=zh_cn&edition=full","pubTime":"2025-04-25 18:06","pubTimestamp":1745575585,"startTime":"0","endTime":"0","summary":"国元证券股份有限公司马云涛近期对太龙药业进行研究并发布了研究报告《首次覆盖报告:大股东持续赋能,多业务齐头并进》,首次覆盖太龙药业给予买入评级。2015年,公司全资收购桐君堂和北京新领先,进军中药饮片和医药研发外包业务,形成了目前药品制剂、中药饮片和药品研发服务三大核心业务板块。公司的中药饮片业务以子公司桐君堂为主开展,近几年收入稳健增长,预计未来有望受益集采,实现快速增长。首次覆盖,给予“买入”评级。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042500031698.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600222","000728"],"gpt_icon":0},{"id":"2530867977","title":"国元证券给予上海电影买入评级,2024年年报及2025年一季报点评:2025Q1业绩高增,以IP带动新业务成长","url":"https://stock-news.laohu8.com/highlight/detail?id=2530867977","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530867977?lang=zh_cn&edition=full","pubTime":"2025-04-25 16:29","pubTimestamp":1745569762,"startTime":"0","endTime":"0","summary":"国元证券04月25日发布研报称,给予上海电影(601595.SH)买入评级。评级理由主要包括:1)2024年表现平淡,2025Q1业绩高增;2)核心业务齐头并进,持续探索IP多元化发展路径。风险提示:电影票房不及预期,IP开发不及预期,行业竞争加剧等。AI点评:上海电影近一个月获得5份券商研报关注,买入4家,增持1家。文章来源:每日经济新闻原标题:国元证券给予上海电影买入评级,2024年年报及2025年一季报点评:2025Q1业绩高增,以IP带动新业务成长","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425164006a46689ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425164006a46689ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["000728","601595"],"gpt_icon":0},{"id":"2529203726","title":"国元证券:公司高度重视市值管理工作,同时会按照既定的战略,努力做好经营管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2529203726","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529203726?lang=zh_cn&edition=full","pubTime":"2025-04-24 16:30","pubTimestamp":1745483448,"startTime":"0","endTime":"0","summary":"证券之星消息,国元证券(000728)04月24日在投资者关系平台上答复投资者关心的问题。投资者提问:您好,公司二级市场表现很不理想,请问针对这种情况公司打算采取哪些措施?在破净状态是否会考虑回购注销等手段来维护股东权益?国元证券回复:尊敬的投资者,您好!公司高度重视市值管理工作,同时会按照既定的战略,努力做好经营管理。公司如有相关披露事项均会根据法律法规及时履行信息披露义务。感谢您的关注。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042400027350.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","000728","BK0183","BK0188","BK0276","BK0012"],"gpt_icon":0},{"id":"2529648660","title":"国元证券:给予锦波生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2529648660","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529648660?lang=zh_cn&edition=full","pubTime":"2025-04-24 12:23","pubTimestamp":1745468605,"startTime":"0","endTime":"0","summary":"国元证券股份有限公司李典近期对锦波生物进行研究并发布了研究报告《2025年一季报点评:一季度业绩高增,激励计划彰显长期信心》,给予锦波生物买入评级。 锦波生物 事件: 公司发布2025年一季度报告。拟授予100万份股票期权,占公告日公司股本总额的1.13%,其中,首次授予80万份,行权价格为每份276元。我们预计2025-2027年公司实现EPS为12.11/16.28/20.54元/股,对应PE为33/25/20x,维持“买入”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042400018702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000728"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1746445908100,"stockEarnings":[{"period":"1week","weight":0.0027},{"period":"1month","weight":-0.0399},{"period":"3month","weight":-0.0593},{"period":"6month","weight":-0.1052},{"period":"1year","weight":0.1281},{"period":"ytd","weight":-0.1009}],"compareEarnings":[{"period":"1week","weight":-0.0053},{"period":"1month","weight":-0.017},{"period":"3month","weight":0.0087},{"period":"6month","weight":0.0021},{"period":"1year","weight":0.0561},{"period":"ytd","weight":-0.0217}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"国元证券股份有限公司","boardCode":"AI0067","boardName":"资本市场服务","stockholders":"99114人(较上一季度减少0.12%)","perCapita":"44027股","listingDate":"1997-06-16","address":"安徽省合肥市蜀山区梅山路18号","registeredCapital":"436377万元","survey":" 国元证券股份有限公司的主营业务是综合金融服务的提供、研发和销售。公司的主要产品是财富信用业务、自营业务、投资银行业务、资产管理业务、机构业务、国际业务。公司荣获安徽省政府“服务地方实体经济发展评价优秀”、中国人民银行与中国证监会“金融科技发展奖”、中国证券业协会。","listedPrice":7.2},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"国元证券(000728)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供国元证券(000728)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"国元证券,000728,国元证券股票,国元证券股票老虎,国元证券股票老虎国际,国元证券行情,国元证券股票行情,国元证券股价,国元证券股市,国元证券股票价格,国元证券股票交易,国元证券股票购买,国元证券股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"国元证券(000728)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供国元证券(000728)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}